Citing a desire for improved patient safety and significant technological advances in recent years, the European Commission (EC) replaced the In Vitro Diagnostic Directive (IVDD) with a new, harmonized regulatory framework: the In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. Here, Agilent shows how it aims to support you and your clinical lab through this regulatory transition.